<DOC>
	<DOCNO>NCT02730572</DOCNO>
	<brief_summary>The primary purpose study identify whether , adjustment confounders via stratification propensity score adjustment calendar year , combine endpoint consist # 1 # 4 ( 1. switch back Concerta , 2. changing use immediate release [ IR ] methylphenidate , 3. begin new attention deficit hyperactivity disorder [ ADHD ] medication , 4. stop Concerta long act [ LA ] methylphenidate { authorized generic [ AG ] methylphenidate equivalent generic [ EG ] methylphenidate } begin index date ) , differ participant switch brand Concerta EG formulation versus participant switch brand Concerta AG formulation .</brief_summary>
	<brief_title>Concerta ( Methylphenidate ) -To-Generic Switch Study</brief_title>
	<detailed_description>This retrospective cohort study base health claim database , Truven Commercial Claims Encounters ( CCAE ) database . Participants enter cohort , use Concerta continuously least 60 day October 3 , 2012 , receive dispense AG EG formulation within 15 day end day Concerta supply . The date dispense AG EG formulation participant index date . This study track various event , example , back-switches , methylphenidate dose change time ( 60 day switch Concerta AG EG generic compare 60 day switch ) .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Male female participant 6 65 year age Have database continuously least 183 day June 1 , 2012 Have diagnosis attention deficit hyperactivity disorder ( ADHD ) Use Concerta ( brand methylphenidate ) least 60 day receive dispense authorize generic ( AG ) equivalent generic ( EG ) formulation within 15 day end day Concerta supply . The date dispense EG AG formulation participant index date Have index date great equal ( &gt; = ) Dec 1 , 2012 less equal ( &lt; = ) Dec 3 , 2014 , former reflect fact EG preparation become available December , 2012 , latter allow 60 day follow &lt; = Jan 31 , 2015 , end date available data Their age sex specify database At time June 1 , 2012 index date receive diagnosis Renal insufficiency Hepatic insufficiency Schizophrenia Bipolar disorder mania Anxiety Glaucoma Tourettes 's syndrome Nervous tension Narrowing esophagus , stomach intestine At time 183 day join cohort 60 day index date , ) diagnose pregnant ; b ) dispense prescription medication commonly use treat seizure migraine c ) dispense antidepressant antipsychotic medication At time 60 day index date 60 day index date ) Receive dispense methylphenidate form nonchewable tablet , example , receive methylphenidate patch , suspension , syrup , chewable tablet b ) Receive dispense long act ( LA ) methylphenidate Concerta , AG formulation EG formulation Concerta dispense participant &lt; = 3 day index date</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
	<keyword>Methylphenidate</keyword>
</DOC>